Addex Therapeutics (ADXN) Equity Ratio (2022 - 2024)
Historic Equity Ratio for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to 0.91.
- Addex Therapeutics' Equity Ratio rose 26725.12% to 0.91 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.91, marking a year-over-year increase of 26725.12%. This contributed to the annual value of 0.91 for FY2024, which is 26725.12% up from last year.
- As of Q4 2024, Addex Therapeutics' Equity Ratio stood at 0.91, which was up 26725.12% from 0.25 recorded in Q4 2023.
- Over the past 5 years, Addex Therapeutics' Equity Ratio peaked at 0.91 during Q4 2024, and registered a low of 0.25 during Q4 2023.
- Moreover, its 3-year median value for Equity Ratio was 0.59 (2022), whereas its average is 0.58.
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 5840.07% in 2023, then skyrocketed by 26725.12% in 2024.
- Over the past 3 years, Addex Therapeutics' Equity Ratio (Quarter) stood at 0.59 in 2022, then plummeted by 58.4% to 0.25 in 2023, then surged by 267.25% to 0.91 in 2024.
- Its Equity Ratio stands at 0.91 for Q4 2024, versus 0.25 for Q4 2023 and 0.59 for Q4 2022.